Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Biotage

141.9

 

SEK

 

+0.07 %

Less than 1K followers

BIOT

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
+0.07%
+0.78%
+27.26%
-11.75%
-6.83%
-23.46%
-25.98%
+0.64%
+43.94%

Biotage operates in the biotechnology industry and focuses on the development and manufacture of products for chemical analysis and preparative chromatography. The company's products are aimed at researchers and laboratories in drug development and food analysis. The operations are international and target companies and institutions globally. Biotage was founded in 1987 and is headquartered in Uppsala.

Read more
Market cap
11.49B SEK
Turnover
154.07M SEK
Revenue
2.06B
EBIT %
18.63 %
P/E
39.97
Dividend yield-%
1.16 %
Financial calendar
16.7
2025

Interim report Q2'25

23.10
2025

Interim report Q3'25

19.2
2026

Annual report '25

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release5/30/2025, 3:00 PM

Change in the number of votes in Biotage AB (publ)

Biotage
Regulatory press release4/24/2025, 12:00 PM

Resolutions at the Annual General Meeting in Biotage AB (publ) on 24 April 2025

Biotage
Biotage, Audiocast with teleconference, Q1'25
Webcast4/23/2025, 7:00 AM

Biotage, Audiocast with teleconference, Q1'25

Biotage

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/22/2025, 6:01 AM

Biotage AB (publ) Interim report January-March 2025

Biotage
Regulatory press release4/22/2025, 6:00 AM

Statement by the Board of Directors of Biotage in relation to the public offer from RWK BidCo

Biotage
Regulatory press release4/3/2025, 11:00 AM

Biotage AB (publ) publishes Annual and Sustainability Report 2024

Biotage
Regulatory press release3/24/2025, 8:00 AM

NOTICE OF ANNUAL GENERAL MEETING OF BIOTAGE AB (PUBL)

Biotage
Biotage, Audiocast with teleconference, Q4'24
Webcast2/19/2025, 8:00 AM

Biotage, Audiocast with teleconference, Q4'24

Biotage
Regulatory press release2/19/2025, 7:00 AM

Biotage AB (publ) Year end Report January-December 2024

Biotage
Biotage, Audiocast with teleconference, Q3'24
Webcast10/23/2024, 8:00 AM

Biotage, Audiocast with teleconference, Q3'24

Biotage
Regulatory press release10/23/2024, 6:00 AM

Biotage AB (publ) Interim report January-September 2024

Biotage
Press release10/8/2024, 3:00 PM

Biotage appoints Nomination Committee

Biotage
Regulatory press release9/30/2024, 3:00 PM

Change in number of shares and votes

Biotage
Regulatory press release9/5/2024, 7:00 PM

Issue and re-purchase of class C shares for incentive program

Biotage
Regulatory press release8/13/2024, 5:45 AM

Biotage AB appointment of new CEO

Biotage
Regulatory press release7/31/2024, 4:45 PM

Change in number of votes

Biotage
Regulatory press release7/31/2024, 3:30 PM

Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan

Biotage
Press release7/17/2024, 6:00 PM

Reclassification of class C shares to ordinary shares and transfer of ordinary shares within the framework of a long-term incentive plan

Biotage
Regulatory press release7/16/2024, 6:00 AM

Biotage AB (publ) Interim report January-June 2024

Biotage
Biotage, Audiocast with teleconference, Q1'24
Webcast4/25/2024, 1:00 PM

Biotage, Audiocast with teleconference, Q1'24

Biotage
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.